7-Bromo-4-chloroquinazoline(CAS: 573675-55-5)

7-Bromo-4-chloroquinazoline (CAS: 573675-55-5) falls under various regulatory guidelines such as REACH in Europe, which requires registration if manufactured or imported in quantities above one tonne per year. In the U.S., it may be subject to reporting under TSCA. Additionally, it complies with GHS classification for hazardous chemicals. EPA regulations may also apply, depending on the intended use or disposal methods.

There are several alternatives to 7-Bromo-4-chloroquinazoline (CAS: 573675-55-5) in synthesis, including 8-Bromo-4-chloroquinazoline and 7-Chloro-4-bromoquinazoline. Synthesis can also be achieved using other reagents like 4-chloro-7-bromoquinazoline (CAS: 574514-47-0), which provides similar functionalities and can be a viable substitute.

The market for 7-Bromo-4-chloroquinazoline (CAS: 573675-55-5) is currently showing a steady growth, particularly in pharmaceutical research due to its potential as a medicinal compound. Recent research trends indicate an increasing interest in its application as a lead molecule in anticancer drug development. Market trends also suggest growing demand from academic and industrial research institutions.

Waste containing 7-Bromo-4-chloroquinazoline (CAS: 573675-55-5) should be collected in appropriate containers and handled according to the waste management regulations. Incineration or professional waste disposal services are recommended, especially if the waste is considered hazardous. Environmental protection measures include proper containment to prevent soil or water contamination, and adherence to local and international environmental protection standards.